September 2016

In late August, the United States Food and Drug Administration (FDA) announced that it will hold a two-day public hearing November…

On October 13, 2016, qordata will be hosting a webinar, “Retrospect and Looking Forward: A Review of Two Full Years of Open…

We have been hearing for years about the opioid crisis our country is facing, a crisis that was partially brought about by abuse…

In an interview with the Financial Times, Joe Jiminez, CEO of Novartis, predicts that November’s election may “trigger a sea…

Pharmaceutical companies have long been dealing with negative press about the supposed “rise of prescription drug costs.” Now,…

In the AseraCare case, the United States Department of Justice (DOJ) sought to show that AseraCare submitted false claims. Relying…

Two weeks ago, in the midst of the hubbub surrounding Mylan and its  EpiPen, Jason Chaffetz and Elijah Cummings, Chairman and…

Late last week, the Kaiser Family Foundation (KFF) released a new report, “Medicare Part D in 2016 and Trends over Time.” The…

In August 2016, the Food and Drug Administration (FDA) launched an updated web-based version of its “Orange Book,” the publication…

Recent plaintiff wins in lawsuits against life sciences companies seeking to recover lost shareholder value resulting from…